1. M. Durante, J.S. Loeffler, Charged particles in radiation oncology. Nature Rev. Clin. Oncol. 7, 37–43 (2010)
2. D. Schardt, T. Elsässer, D. Schulz-Ertner, Heavy-ion tumor therapy: physical and radiobiological benefits. Rev. Mod. Phys. 82, 383–425 (2010)
3. M.H. Baron, P. Pommier, V. Favrel, G. Truc, J. Balosso, J. Rochat, ETOILE project, A “One-day survey”: as a reliable estimation of the potential recruitment for proton- and carbon-ion therapy in France. Radiother. Oncol. 73, 15–17 (2004)
4. R. Mayer, U. Mock, R. Jager, R. Potter, C. Vutuc, H. Eiter, K. Krugmann, J. Hammer, B. Hirn, R. Hawliczek, T.H. Knocke-Abulesz, P. Lukas, E. Nechville, B. Pakisch, M. Papauschek, R. Wolfgang, W. Rhomberg, H. Sabitzer, A. Schratter-Sehn, S. Felix, I. Wedrich, T. Auberger, Epidemiological aspects of hadron therapy: a prospective nationwide study of the Austrian project MedAustron and the Austrian Society of Radiooncology (OEGRO). Radiother. Oncol. 73, 24–28 (2004)
5. S.V. Bulanov, T.Z. Esirkepov, V.S. Khoroshkov, A.V. Kunetsov, F. Pegoraro, Oncological hadrontherapy with laser ion accelerators. Phys. Lett. A 99, 240–247 (2002)